share_log

樂普生物-B:自願性公告MRG003用於治療復發性╱ 轉移性鼻咽癌(R/M NPC)獲FDA授予突破性治療藥物認定

LEPU BIO-B: VOLUNTARY ANNOUNCEMENTBREAKTHROUGH THERAPY DESIGNATION GRANTEDBY THE FDA TO MRG003 FOR THE TREATMENT OF R/M NPC

HKEX ·  Aug 4 20:04
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more